Preparation of extended release solid dispersion formulations of tacrolimus using ethylcellulose and hydroxypropylmethylcellulose by solvent evaporation method

• Published in: Journal of pharmacy and pharmacology Vol. 68; no. 3; p. 316
• Main Authors: Tsunashima, Daisuke, Yamashita, Kazunari, Ogawara, Ken-Ichi, Sako, Kazuhiro, Higaki, Kazutaka
• Format: Journal Article
• Language: English
• Published: England 01.03.2016
• Subjects: Administration, Oral; Animals; Biological Availability; Cellulose - analogs & derivatives; Cellulose - chemistry; Chemistry, Pharmaceutical - methods; Delayed-Action Preparations - chemistry; Delayed-Action Preparations - metabolism; Drug Carriers - chemistry; Hypromellose Derivatives - chemistry; Lactose - chemistry; Macaca fascicularis; Male; Solubility; Solvents - chemistry; Tacrolimus - chemistry; Tacrolimus - metabolism; Water - chemistry; pharmacokinetics; controlled release; solid dispersion; dissolution; oral absorption
• ISSN: 2042-7158
• DOI: 10.1111/jphp.12515

Tacrolimus is a poorly water-soluble compound that is used to prevent allograft rejection. We aimed to prepare an extended release formulation of tacrolimus to achieve both an extended release profile and improved solubility of tacrolimus. Extended release granules (ERG) of tacrolimus were prepared with lactose, ethylcellulose (EC) and hydroxypropylmethylcellulose (HPMC) via the solvent evaporation method. In an in vitro release study, ERG had an extended release profile, and the release rate of tacrolimus was regulated by the quantity of lactose, EC and HPMC in the formulation. HPMC-containing ERG successfully enhanced and maintained supersaturation of tacrolimus even after 24 h in a supersaturated release study. In contrast, the extent of supersaturation rapidly decreased after 4 h and the concentration nearly reached the same level as that of crystalline tacrolimus at 24 h for ERG without HPMC. In vivo absorption characteristics were compared between ERGs and immediate release (IR) formulation of tacrolimus. Successful and sustained absorption of tacrolimus without reducing bioavailability compared with IR formulation was observed for ERG. These results suggest the feasibility of combining an EC-based formulation with solid dispersion utilizing HPMC for the extended release of oral formulations and sustained absorption of tacrolimus.